Sign Up
Stories
AI-Driven Discovery and Insurance Innovation
Share
Advancements in Cancer Treatment and Mar...
BenevolentAI's Strategic Shareholder Let...
Biotech Innovation: Lung Models and Mach...
4P-Pharma Secures €15 Million Funding
ACTICOR BIOTECH: Financial Report Postpo...
AI Boosts Healthcare Efficiency
Overview
API
Belfast-based Amply Discovery secures £1.4M grant funding for AI-powered drug discovery platform, while Hong Kong-based MediConCen raises $6.85M in Series A funding for international expansion and AI-driven insurance claims automation.
Ask a question
How might the democratization of drug discovery by Amply Discovery impact the pharmaceutical industry and patient outcomes?
In what ways could the advancements in AI-driven drug discovery and insurance claims automation influence the future of healthcare and financial services?
What are the potential implications of MediConCen's AI-driven insurance claims automation for the insurance industry and consumer experience?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Nov 2023
Dec 2023
Jan 2024
Feb 2024
Coverage
finsm
irish